title: Consider stopping dengvaxia administration without immunological screening.
authors.affiliation: a Department of Mathematics , Centro de Matemática e Aplicações Fundamentais da Universidade de Lisboa , Lisboa , Portugal.
authors.forename: Maíra
authors.initials: M
authors.lastname: Aguiar
authors.affiliation: b Department of Preventive Medicine and Biometrics , Uniformed Services University of the Health Sciences , Bethesda , MD , USA.
authors.forename: Scott B
authors.initials: SB
authors.lastname: Halstead
authors.affiliation: a Department of Mathematics , Centro de Matemática e Aplicações Fundamentais da Universidade de Lisboa , Lisboa , Portugal.
authors.forename: Nico
authors.initials: N
authors.lastname: Stollenwerk
mesh_terms: D000367:Age Factors; D000914:Antibodies, Viral / Q000097:blood*; D003715:Dengue / Q000473:pathology* / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000008:administration & dosage* / Q000009:adverse effects*; D006760:Hospitalization; D006801:Humans; D008962:Models, Theoretical
chemical_list: D000914:Antibodies, Viral; D053059:Dengue Vaccines
keywords: Dengvaxia; immunological screening; modeling; prediction; vaccine disease-enhancement